Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Recommendation of "Moderate Buy" by Brokerages
MarketBeat
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty analysts that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating, t
NASDAQ:IONS